RxDoctor Payments Data

Carol Cdebaca

Surgical · Chester, VANPI 1154518900

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Boston Scientific at 30.3% of the total. Among surgical clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,815in general payments, 2019–2025

Across 166 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$574
  • Collegium Pharmaceutical, Inc.$420
  • Mallinckrodt Hospital Products Inc.$364
  • AbbVie$233
  • Pfizer$162
  • plus $905 from 17 others

What the payments were for

  • Food & beverage$3,815100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,815 in reported general payments places this provider in the 90th percentile of 201 surgical providers in Virginia.

See all surgical providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate14$22,924
MovantikNaloxegol Oxalate22$10,373
Lidocaine96$9,803
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen469$8,650
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen338$7,544
Buprenorphine21$5,630
Gabapentin294$4,663
Tizanidine Hcl93$3,864
Diclofenac Sodium68$2,625
Pregabalin165$2,542
Baclofen135$2,527
Fentanyl19$2,319
Tramadol Hcl ErTramadol Hcl32$1,898
Oxycodone Hcl85$1,887
Cyclobenzaprine Hcl170$1,617

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$162$22,92414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 201 surgical providers in Virginia.

Other surgical in Chester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →